NFAT5 and liver cancer: The results indicated that aberrant expression of NFAT5 was negatively correlated with the histologic grade (P = 0.035), HBV infection (P < 0.01) and the Barcelona Clinic Liver Cancer (BCLC) stage (P < 0.01).